Apolipoprotein E4 (ApoE4) causes disruption of glypican-1 recycling and processing in ApoE4/4 fibroblasts and induced neurons.
The apolipoprotein E4 (ApoE4) isoform confers increased risk of developing Alzheimer's disease. ApoE2 and ApoE3 can be S-nitrosylated (Cys-SNO), but not ApoE4. The recycling heparan sulfate (HS) proteoglycan glypican-1 (GPC1) can also carry SNO and release HS by a Cu/NO dependent cleavage. ApoE3/3 and ApoE4/4 fibroblasts and the respective induced neurons (-iN) were exposed to inhibitors of NO-synthases (NOS), to NO donor or ascorbate and examined by immunofluorescence microscopy. Exposure to NO donor increased co-localization between ApoE3-SNO and GPC1 in ApoE3/3 fibroblasts. Co-localization between ApoE3 and GPC1 diminished when cNOS/NOS3 was inhibited in ApoE3/3 fibroblasts. Exposure to NO donor or ascorbate indicated almost fully utilized capacity to release HS from GPC1. When nNOS/NOS1 and iNOS/NOS2 were inhibited in ApoE3/3-iN, release of HS decreased, and exposure to ascorbate again showed that the capacity to release HS was almost fully utilized. In ApoE4/4 fibroblasts endosome transport was retarded and HS and GPC1-SNO accumulated in late endosomes. Inhibition of cNOS/NOS3 in ApoE4/4 fibroblasts had no effect on HS release but inhibition of iNOS/NOS2 had a substantial effect. Exposure to NO donor or ascorbate revealed unutilized capacity to release HS from GPC1. In ApoE4/4-iN, nNOS/NOS1 and iNOS/NOS2 were major producers of NO. Inhibition of nNOS/NOS1 and iNOS/NOS2 in ApoE4/4-iN again showed unutilized capacity to release HS. We propose that expression of ApoE4, which retards endosome trafficking, but also activates iNOS/NOS2, results in accumulation of GPC1-SNO and slow exit of HS from endosomes which can be restored by ascorbate.
Authors
- Katrin Mani (ORCID: https://orcid.org/0000-0002-1821-0634)
- Fang Cheng
- Lars-Ake Fransson
Institutions
- Lund University (SE)
Publication Details
- Journal
- PubMed
- Published
- 2026-11-14
- DOI
- https://doi.org/10.1093/glycob/cwag109
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00